Last checked at 
4 Nov 14 07:17
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
7,005.00
Bid:
7,021.00
Ask:
7,022.00
Change:
0.00
(0.00%)
Spread:
1.00 (0.01%)
Open:
6,927.00
High:
7,023.00
Low:
6,849.00
Yest. Close:
6,858.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.4 Nov 14 06:133 Nov 14 16:08Astrazeneca gains rights to Almirall respiratory franchise
Astrazeneca has gained the development and commercialisation rights to Almirall's respiratory franchise, giving it access to all on-market revenues, the drugs maker said. The group will pay an initial $875m, plus up to a further $1.22bn in development, launch and sales-related milestones. The deal,
3 Nov 14 07:103 Nov 14 06:15London pre-open: Chinese PMI data to drag FTSE lower early on
Tracking a weaker session in Asia overnight, UK stocks are expected to begin a macro-focused week with small gains. City sources predict the FTSE 100 will open around nine points lower than Friday's close of 6,546.47. "As we approach a major week in the markets in terms of economic events, we are l
2 Nov 14 17:3331 Oct 14 16:1831 Oct 14 06:1930 Oct 14 16:10London open: Miners drag UK stocks lower, but Barclays gains
London's stock exchange opened more or less flat on Thursday as heavy falls from mining stocks and BT offset gains from Barclays and St James's Place. The FTSE 100 was trading 0.1% lower at 6,449 in early deals. The subdued start follows a weak performance on Wall Street overnight as investors reac
30 Oct 14 08:34Astrazeneca type 2 diabetes drug approved for use by US FDA
Astrazeneca's Xigduo XR type 2 diabetes treatment has been approved for use in adults by the US Food and Drug Administration (FDA). The drug, which is already approved in Australia, is taken as a once-daily tablet that removes glucose from the body via the kidneys. "The addition of Xigduo XR to our
30 Oct 14 07:48